Herbert Loong, Advisor at Greater Bay Area International Clinical Trial Institute, and Steering Committee Member at Lung Cancer Policy Network, shared on X:
“Excellent overview by my friend and colleague James Chow from QEH in Hongkong on the possibility of behavioural interventions in survivorship and reducing risks of secondary cancers.
As clinicians, we are in a position to not only treat the current cancer, but intercept any future ones.”
See related images below
Other articles about secondary cancers on OncoDaily.
